Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

83393 Press Releases
DateTitleCompany
29 Jul 15 Cytori Appoints VP of Business Development and General Counsel Cytori Therapeutics, Inc.,
Published by
Business Wire
29 Jul 15 Cardax Product Candidates Demonstrate Superior Bioavailability vs. Microalgal Astaxanthin in Monkey Study Cardax, Inc.,
Published by
Business Wire
29 Jul 15 Evogene Announces Discovery and Validation of Novel Plant Targets for Herbicides Evogene Ltd.,
Published by
Business Wire
29 Jul 15 ARIAD to Receive up to $200 Million Through Iclusig Non-Dilutive Synthetic-Royalty Financing with PDL BioPharma ARIAD Pharmaceuticals, Inc.,
Published by
Business Wire
29 Jul 15 Highland Therapeutics Announces Initiation of Pivotal Trial of HLD-200 in Pediatric ADHD Patients Highland Therapeutics Inc.,
Published by
Business Wire
29 Jul 15 Myriad to Announce Fiscal Fourth Quarter 2015 Financial Results on August 11, 2015 Published by
GlobeNewswire
29 Jul 15 Galena Biopharma Launches Zuplenz(R) (ondansetron) Oral Soluble Film Published by
GlobeNewswire
29 Jul 15 Conatus Pharmaceuticals to Report Second Quarter 2015 Financial Results Published by
GlobeNewswire
29 Jul 15 Loxo Oncology to Conduct Conference Call and Webcast of Second Quarter Financial Results Published by
GlobeNewswire
29 Jul 15 CytoDyn Completes Qualification of PRO 140 Material for Phase 3 Published by
GlobeNewswire
29 Jul 15 Nutrition Business Journal Honors ChromaDex With Business Achievement Award for Growth Published by
GlobeNewswire
29 Jul 15 What Are 'Eye Crusties' Made Of? uBiome Invites Citizen Scientists to Find Out Published by
GlobeNewswire
29 Jul 15 Bellerophon Therapeutics Expands License Agreement With INO Therapeutics to Develop INOpulse(R) for Three Additional Cardiopulmonary Diseases Published by
GlobeNewswire
29 Jul 15 Sanofi Announces that First LixiLan Phase III Study Met Primary Endpoint Sanofi,
Published by
PR Newswire
29 Jul 15 Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo Mylan N.V.,
Published by
PR Newswire
29 Jul 15 World Health Organization Accepted "Piclidenoson" as Proposed New Generic Name for Can-Fite's Lead Drug Candidate CF101 Can-Fite BioPharma Ltd.,
Published by
PR Newswire
29 Jul 15 Cogentix Medical to Announce First Quarter Fiscal 2016 Results on August 10, 2015 Cogentix Medical, Inc.,
Published by
PR Newswire
29 Jul 15 AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. AcelRx Pharmaceuticals, Inc.,
Published by
PR Newswire
29 Jul 15 RXi Pharmaceuticals to Webcast Second Quarter 2015 Financial Results on Wednesday, August 12, 2015 RXi Pharmaceuticals Corporation,
Published by
PR Newswire
29 Jul 15 'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms Cepheid,
Published by
PR Newswire
29 Jul 15 Synthetic Biologics to Report Second Quarter Results on August 10, 2015 Synthetic Biologics, Inc.,
Published by
PR Newswire
29 Jul 15 Frozen Food Foundation Names Dr. Erdogan Ceylan of Silliker 2015 Freezing Research Award Recipient Frozen Food Foundation,
Published by
Business Wire
29 Jul 15 Biodesix Adds Biognosys’ Proteomics Technology to its Diagnostic Development Capabilities Biodesix, Inc.,
Published by
Business Wire
29 Jul 15 GE Healthcare to invest in enhanced training for over two million health professionals globally by 2020 GE Healthcare,
Published by
Business Wire
29 Jul 15 Notice of Results Published by
GlobeNewswire
29 Jul 15 Judge Pushes Back Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding Legal-Bay LLC,
Published by
PR Newswire
29 Jul 15 Health 2.0 Announces Inaugural Care Delivery Symposium 2015 Health 2.0,
Published by
PR Newswire
29 Jul 15 CORRECTION: Sanofi has announced that the first LixiLan Phase III trial, LixiLan-O, met primary study endpoint Published by
GlobeNewswire
29 Jul 15 Sanofi has announced that the first LixiLan Phase III trial, LixiLan-O, met primary study endpoint Published by
GlobeNewswire
29 Jul 15 Novartis partners with Phase 4 Partners and institutional investors to help create Mereo BioPharma Group Ltd Novartis International AG,
Published by
GlobeNewswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.